Furthermore, our recent study showed that Eb significantly attenuates pro-inflammatory and pro-atherosclerotic mediators as well as diabetes-associated atherosclerosis and diabetic nephropathy after 20 weeks of treatment in the diabetic ApoE/GPx1 dKO mice [25]. This evidence concerns the gene GPX1 and diabetes mellitus.